Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Yoshihiro Motomiya"'
Publikováno v:
Cell Transplantation, Vol 13 (2004)
For research in regenerative medicine, not only the study of cellular pluripotency but also knowledge of the reorganization of tissue structure is crucial. However, the latter will probably be more difficult to acquire. When small fragments of kidney
Externí odkaz:
https://doaj.org/article/abb4a80be4b841268a0440df1b55f441
Autor:
Yoshihiro Motomiya
Publikováno v:
International Journal of Clinical Nephrology. 4:01-05
β2m is a precursor protein of the dialysis-related amyloidosis (DRA) and β2m lacking the N-terminal six residues of the mature protein (ΔN6β2m) is a one of amyloidogenic variant of β2m. In the previous study, we had showed an unfolding in the C-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb00b7e8d88d45305e80ca0619097119
https://doi.org/10.31579/2834-5142/041
https://doi.org/10.31579/2834-5142/041
β2-Microglobulin (β2M) occurs as a precursor protein in dialysis-related amyloidosis (DRA), which is a major complication in lives of patients undergoing dialysis. However, the underlying mechanism by which a native β2M transform into an amyloid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8fc3efeb20f9be823b2556a1193b1b
Autor:
Yoshihiro Motomiya
Publikováno v:
International Journal of Clinical Case Reports and Reviews. 2:01-04
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c186c0b18db8c28a60657602cabe2719
https://doi.org/10.31579/2690-4861/019
https://doi.org/10.31579/2690-4861/019
Autor:
Tatsuo Yoneda, Kiyohide Fujimoto, Shunta Hori, Yoshihiro Motomiya, Yoshinori Uji, Katsunori Yoshida
Publikováno v:
Nihon Toseki Igakkai Zasshi. 52:451-455
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47e9a8388c52707b8661b52b0f48b43e
https://doi.org/10.4009/jsdt.52.451
https://doi.org/10.4009/jsdt.52.451
Autor:
Naoki Miura, Kota Nakatomi, Yuto Ishikawa, Salunya Tancharoen, Ikuro Maruyama, Ko-ichi Kawahara, Ronny Christiadi Salim, Hikari Ueno, Issey Kanemoto, Yoshihiro Motomiya, Kiyoshi Kikuchi, Kiyoshi Matsumura, Yuki Mori, Hitoshi Imaizumi, Emiko Okuda‑Ashitaka, Taketo Omori
Publikováno v:
Biomedical Reports
Nucleophosmin 1 (NPM1) primarily localizes to the nucleus and is passively released into the extracellular milieu by necrotic or damaged cells, or is secreted by monocytes and macrophages. Extracellular NPM1 acts as a potent inflammatory stimulator b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd5c28f830a51c2619d9a0908c5e06f
https://doi.org/10.3892/br.2020.1397
https://doi.org/10.3892/br.2020.1397
Autor:
Hiroyuki Morita, Yoshifumi Ubara, Shunsuke Goto, Suguru Yamamoto, Takashi Shigematsu, Hideki Fujii, Kenmei Takaichi, Yukio Ando, Junichi Hoshino, Kunihiro Yamagata, Mitsuharu Ueda, Yoshihiro Motomiya, Shinichi Nishi
Publikováno v:
Nephrology. 23:640-645
Aim Dialysis-related amyloidosis (DRA) exhibits multiple bone-articular lesions, such as carpal tunnel syndrome (CTS), trigger finger (TF), spinal canal stenosis (SCS), destructive spondyloarthropathy (DSA), bone cysts, and joint pains. DRA leads to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48d832b334c06e8596ea33984dbbec15
https://doi.org/10.1111/nep.13077
https://doi.org/10.1111/nep.13077
Publikováno v:
Therapeutic Apheresis and Dialysis. 22:61-66
Dialysis-related amyloidosis (DRA) is a severe complication of hemodialysis that results in progressive destruction of bones and joints. Elevated concentrations of the β2-microglobulin (β2m) level in the serum of subjects on hemodialysis promote th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5199f37a97829c68025dfe4c560cfb43
https://doi.org/10.1111/1744-9987.12591
https://doi.org/10.1111/1744-9987.12591
Autor:
Tancharoen Salunya, Yoshihiro Motomiya, Yasuki Motomiya, Ikuro Maruyama, Yoko Oyama, Munekazu Yamakuchi, Tanaka Kenji
Publikováno v:
Therapeutic Apheresis and Dialysis. 21:395-404
Chronic kidney disease (CKD) has been known to be a state of excessive fibroblast growth factor-23 (FGF23) and α-Klotho deficiency. Patients undergoing hemodialysis have an increased mortality risk associated with cardiovascular disease and endothel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64e4c81a072a663aa29cd84a3011a5f6
https://doi.org/10.1111/1744-9987.12524
https://doi.org/10.1111/1744-9987.12524
Autor:
Akiko Sakasai-Sakai, Yoshihiro Motomiya, Hirokazu Suzuki, Masayoshi Takeuchi, Ikuro Maruyama, Takanobu Takata
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports
The anhydrofructose pathway is an alternate pathway for glycogen degradation by α-1,4-glucan lyase. The sugar 1,5-anhydro-D-fructose (1,5-AF) acts as the central intermediate of this pathway, but its physiological role of in mammals is unclear. Glyc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d8280f67abafe4789a6c1c9e596105
https://doi.org/10.1038/s41598-019-46333-2
https://doi.org/10.1038/s41598-019-46333-2